Novartis pays $7.8 billion for Abogen mRNA asset
Novartis agreed to pay up to $7.8 billion for global rights to an early-stage mRNA therapy from China's Abogen Biosciences, the latest and largest in
AstraZeneca
Every Fin-node story mentioning AstraZeneca — 7 stories, newest first.
AstraZeneca · 7 stories
AstraZeneca puts $2 billion into Summit Therapeutics
AstraZeneca agreed to invest $2 billion in Summit Therapeutics on Monday, sending the biotech’s shares up as much as 19 percent in after-hours trading
AstraZeneca-Bristol Myers merger talk collapses under weight of its own logic
AstraZeneca shares fell roughly 9 percent early this month after the Financial Times reported the U.K. drugmaker was close to a merger with Bristol My
AstraZeneca BMY Merger Talk Triggers Selloff
AstraZeneca shares fell roughly 9 percent after the Financial Times reported the U.K. drugmaker was close to merging with Bristol Myers Squibb in a de
Novo Nordisk drops 10% as heart drug fails in Phase III
Novo Nordisk shares fell 10% last week after its experimental cardiovascular drug ziltivekimab failed to prevent heart attacks, strokes or cardiovascu
Dow Hits Record on Iran Talks Optimism
The Dow Jones Industrial Average closed at a record high Monday as optimism around U.S.-Iran talks lifted sentiment, though the session's sector rotat
AstraZeneca shares fall on BMS merger talks
AstraZeneca shares dropped 6.1 per cent to 11,860p in early London trading on Monday after the Financial Times reported the UK drugmaker has held talk